Determinants of parental demand of human papillomavirus vaccination for adolescent daughters in China: Contingent valuation survey

Abstract Background Several types of human papillomavirus (HPV) vaccines have been approved for use in adolescent girls in China. These vaccines are regulated as non‐National Immunisation Program vaccines and are optional and generally fully self‐paid by vaccinees. Objective To assess parents' demand for HPV vaccination by eliciting their willingness‐to‐pay for their adolescent daughters to be vaccinated against HPV and to examine the determinants of demand for HPV vaccination in China. Methods A contingent valuation survey was conducted across three cities in Shandong Province in eastern China. We selected 11 junior middle schools with different socioeconomic features and randomly selected 6 classes in each school, and questionnaires were distributed to all girls aged 12–16 in the 66 classes for their parents to complete. A payment card approach was used to elicit parental willingness‐to‐pay for HPV vaccination for their daughters. We also collected a wide array of socioeconomic and psychological variables and interval regressions were applied to examine the determinants of parental willingness‐to‐pay. Results A total of 1074 eligible parents who completed valid questions were included in analyses. Over 85% of parents believed HPV vaccines were, in general, necessary and beneficiary. However, only around 10% believed that their daughters would be infected by HPV. About 8% of parents would not accept HPV vaccine even if the vaccine were free mainly due to concerns about the potential side effects and vaccine safety and quality issues, and 27.37% would only accept the vaccine if it were free. The median willingness‐to‐pay was 300 CNY (42 USD). Several factors were positively correlated with higher willingness‐to‐pay: income, urban residence (relative to rural residence), mothers (relative to fathers), parents' beliefs about vaccine benefits, whether they should make decisions for their daughters, and whether their daughters would be susceptible to HPV. Though education‐level was not significantly correlated with willingness‐to‐pay in the main regressions, a subgroup analysis revealed interesting dynamics in the relation between education and willingness‐to‐pay across different income‐levels. Conclusions There is a large gap between parents' willingness‐to‐pay and the market price of HPV vaccine for girls in China. Parents generally believed the HPV vaccines were beneficial and necessary but when asked for their daughters, most parents did not believe their daughters would be infected by HPV despite the high prevalence in China. Future focus should be on ensuring the provision of accurate health information about HPV prevalence, vaccine quality, and safety to promote vaccine uptake, and promotional efforts tailored to different income groups might yield better effects. Government involvement in negotiating more widely acceptable and affordable prices or subsidising may be necessary for protecting high‐risk population groups.